Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipotassium oxalate toothpaste for dentinal hypersensitivity
NCT03965039Completed
- Sponsor
- Procter & Gamble
- Start
- Jul 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dipotassium oxalate in dentin hypersensitivity (DH) (4 arms), sponsored by Procter & Gamble. Primary endpoint: Air Challenge Schiff Sensitivity Score at 4 weeks. Started Jul 2019; status: completed.
02
Drugs
dipotassium oxalate
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT03965039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03965039.